Antinociceptive action of FK506 in mice.
Immunophilins are abundantly present in the brain as compared to the immune system. Immunophilin-binding agents like FK506 are known to inactivate neuronal nitric oxide synthase (nNOS) by inhibiting calcineurin and decrease the production of nitric oxide. Nitric oxide is involved in the mediation of nociception at the spinal level. In the present study, the effect of FK506 on the tail flick response in mice and the possible involvement of NO-L-arginine pathway in this paradigm was evaluated. FK506 (0.5, 1 and 3 mg/kg, ip) produced a significant antinociception in the tail flick test. Nitric oxide synthase (NOS) inhibitor L-NAME significantly and dose dependently (10-40 mg/kg, ip) potentiated the FK506 (0.5 mg/kg)-induced antinociception. On the other hand, NOS substrate L-arginine (100, 200 and 400 mg/kg) inhibited the FK506-induced antinociception in a dose-dependent manner. Concomitant administration of L-NAME (20 and 40 mg/kg) with L-arginine (200 mg/kg) blocked the inhibition exerted by L-arginine on the FK506-induced antinociception. Thus, it was concluded that NO- L-arginine pathway may be involved in the FK506-induced antinociception in tail flick test.
Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.
Amanpreet
A
Singh
Gaurav
G
Kumar
Pattipati S
PS
Naidu
Shrinivas K
SK
Kulkarni
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001120:Arginine / Q000502:physiology; D008297:Male; D051379:Mice; D009569:Nitric Oxide / Q000502:physiology; D016559:Tacrolimus / Q000494:pharmacology
D000700:Analgesics; D009569:Nitric Oxide; D001120:Arginine; D016559:Tacrolimus